Patients, carers and advocates say better evidence is needed on the safety of ketamine for depression after long-term use, and that those prescribed it must be closely monitored. These are the results of a study undertaken as part of a collaboration between the NIHR Oxford Health Biomedical Research Centre and NIHR Maudsley Biomedical Research Centre….
News
Academic Writing Retreat for Nurses – September 2019
Oxford Health BRC is supporting a three day Academic Paper Writing Retreat for Nurses planned for this September. The retreat, also sponsored by the Oxford cognitive health Clinical Research Facility and the Oxford Institute for Nursing, Midwifery and Allied Health Research, is designed to provide uninterrupted time and space to write up a paper for…
gameChange clinical trial – how virtual reality could transform psychological therapy in the NHS
A new clinical trial beginning on 1st July is testing a virtual reality (VR) based psychological therapy for people with severe mental health difficulties. gameChange is the largest ever clinical trial of virtual reality for a mental health disorder. Over 400 NHS patients across England (Bristol, Manchester, Newcastle, Nottingham and Oxford) will take part in…
Analysis of antidepressant dosage highlights need for new clinical guidelines
Analysis published earlier this month in The Lancet Psychiatry shows that a lower dose of the most commonly used second-generation antidepressants achieves the best balance of effectiveness and tolerability in the acute treatment of adults with major depression. The study, funded by the National Institute for Health Research, has important clinical implications for guidelines and…
New spinout from Oxford – Cristal Health
Cristal Health, a new spinout from Oxford, has been developed as a sustainable way to accelerate the UK-CRIS programme. The UK-CRIS network operates a managed service for secure access to one of the world’s largest repositories of de-identified patient data relating to mental health and dementia conditions. Read the full story on the University of…
Join our patient advisory group for a new research study!
Do you have experience of treatment resistant depression either as a patient or a carer? Are you interested in medical research? Would you like to share your experience and interest to contribute to a new research study? We are setting up a Patient Advisory Group for a new research trial that will evaluate the drug…
